|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | MR molec- ular imaging and fluorescence microscopy for identifi- cation of activated tumor endothelium using a bimodal lipidic nanoparticle显示文摘 | Mulder WJ Strijkers GJ Habets JW | 2005 | FASEB J2005，19，14： | 1 |
| 2 | Quantum dots with a bimodal molecular imaging probe显示文摘 | Mulder WJ Koole R Brandwijk RJ | 2006 | Nano Lett2006，6，： | 1 |
| 3 | A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets显示文摘 | MULDER WJ STRIJKERS GJ GRIFFIOEN AW et ol | 2004 | Bioeonjug Chem2004，15，4： | 1 |
| 4 | Magnetic and fluo- rescent nanoparticles for muhimodality imaging显示文摘 | Mulder WJ Griffion AW Strijkers GJ | 2007 | Nanomedicine ( Lond)2007，2，3： | 1 |
| 5 | Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes显示文摘 | Van Tilborg GA Mulder WJ van der Schaft DW | 2008 | Neoplasia2008，10，12： | 1 |
| 6 | MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle显示文摘 | Mulder WJ Strijkers GJ Habets JW | 2005 | FASEB J2005，19，14： | 1 |
| 7 | Magnetic resonance imaging of vulnerable atherosclerotic plaques:current imaging strategies and molecular imaging probes显示文摘 | Briley-Saebo KCI Mulder WJ Mani V | 2007 | J Magn Reson Imaging2007，26，： | 1 |
| 8 | Imaging neuroin- flammation after stroke: current status of cellular and molecular MRI strategies 显示文摘 | Deddens LH Van Tilborg GA Mulder WJ | 2012 | C erebrovasc Dis2012，33，4： | 1 |
| 9 | Imaging and nanomedicine in inflammatory atherosclerosis显示文摘 | Mulder WJ Jaffer FA Fayad ZA | 2014 | Sci Transl Med2014，6，23： | 1 |
| 10 | Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery显示文摘 | Aukema AAC Mulder PGH Fokkens WJ | 2005 | J Allergy Clin Immunol2005，115，5： | 1 |
| 11 | Influence of p53 status on the HSV-Tk/GCV-induced bystander effect in a panel of human ovarian carcinoma cell lines显示文摘 | Van Dillen IJ Mulder NH Sluiter WJ | 2005 | Oncol Res2005，15，3： | 1 |
| 12 | A liposomalsystem for contrast-enhanced magnetic resonance imagingof molecular targets 显示文摘 | Mulder WJ Strijkers GJ Griffloen AW | 2004 | Bioconjug Chem2004，15，4： | 1 |
| 13 | Evaluation of Cladribine treatment in refractory celiac disease type Ⅱ显示文摘AIM: To evaluate cladribine [2-chlorodeoxyadenosine (2-CdA)] therapy in refractory celiac disease (RCD) Ⅱ. METHODS: An open-label cohort-study of RCD Ⅱ patients treated with 2-CdA was performed between 2000 and 2010. Survival rate, enteropathy associated T-cell lymphoma (EATL) occurrence, clinical course, and histological and immunological response rates were evaluated. RESULTS: Overall, 32 patients were included with a median follow-up of 31 mo. Eighteen patients responded well to 2-CdA. Patients responsive to 2-CdA had a statistically significant increased survival compared to those who were unresponsive. The overall 3- and 5-year survival was 83% in the responder and 63% and 22% in the non-responder group, respectively. The overall 2-year clinical, histological and immunological response rates were 81%, 47% and 41%, respectively. Progression into EATL was reported in 16%, all of these patients died. CONCLUSION: Treatment of RCD Ⅱ with 2-CdA holds promise, showing excellent clinical and histological response rates, and probably less frequent transition into EATL. | Greetje J Tack Wieke HM Verbeek Abdul Al-Toma Dirk J Kuik Marco WJ Schreurs Otto Visser Chris JJ Mulder | 2011 | World Journal of Gastroenterology2011，17，4： | 1 |
| 14 | Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging显示文摘 | Mulder WJ Strijkers GJ van Tilborg GA | 2006 | NMR Biomed2006，19，： | 1 |
| 15 | Carbonic anhydrase IX ex- pression in clear cell renal cell carcinoma and normal tissues: ex- periences from (radio) immunotherapy显示文摘 | Brouwers AH Mulders PF Oyen WJ | 2008 | J Clin 0ncol2008，26，22： | 1 |
| 16 | Consequences of chemoresistance for the herpes simplex virus thymidine ki- nase/ganciclovir-induced bystander effect in a human small cell lung cancer cell line model 显示文摘 | Van Dillen IJ Mulder NH Sluiter WJ | 2005 | Anticancer Res2005，25，1： | 1 |
| 17 | Food doesnot affect the pharmacokinetics of solifenacin, a new muscarinicreceptor antagonist : results of a randomized crossover trial 显示文摘 | UCHIDA T KRAUWINKEL WJ MULDER H | 2004 | BrJ Clin Pharmacol2004，58，1： | 1 |
| 18 | Magnetic resonance imaging of vulnerable atherosclerotic plaques: current Imaging strategies and molecular imaging probes显示文摘 | Briley-Saebo KC Mulder WJ Mani V | 2007 | J Magn Reson Imaging2007，26，3： | 1 |
| 19 | Effect of age on the pharmacokinetics of solifenacin in men andwomen显示文摘 | KRAUWINKEL WJ SMULDERS RA MULDER H | 2005 | Int J Clin Pharmacol Ther2005，43，5： | 1 |
| 20 | Solifenacin demonstrates high absolute bioavailability in healthymen显示文摘 | KUIPERS ME KRAUWINKEL WJ MULDER H | 2004 | Drugs R D2004，5，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员